| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178067 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 07/21/2011 | US20110178066 Hydroxypiperidine derivatives and uses thereof |
| 07/21/2011 | US20110178063 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 07/21/2011 | US20110178061 Heterocyclic derivatives for modulation of calcium channels |
| 07/21/2011 | US20110178050 Use of cyclolignans for the treatment of a hyperactive immune system |
| 07/21/2011 | US20110178047 Oxylipins From Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
| 07/21/2011 | US20110178044 Transdermal administration of hydrophilic drugs using permeation enhancer composition |
| 07/21/2011 | US20110178041 Heterocyclic biaryl derivative and pde inhibitor comprising same as active ingredient |
| 07/21/2011 | US20110178030 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 07/21/2011 | US20110178026 Ricin-like toxins for treatment of cancer |
| 07/21/2011 | US20110178023 Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands |
| 07/21/2011 | US20110178020 Methods and compositions for inhibition of neutrophil exocytosis |
| 07/21/2011 | US20110177951 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof |
| 07/21/2011 | US20110177171 Oxygenated Ophthalmic Compositions and Methods of Use |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177150 Implantable tissue compositions and method |
| 07/21/2011 | US20110177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders |
| 07/21/2011 | US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications |
| 07/21/2011 | US20110177104 Method for selective depletion of cd137 positive cells using anti-cd137 antibody-toxin complex |
| 07/21/2011 | US20110177096 Use of gpr151 modulators for the treatment of pain |
| 07/21/2011 | US20110177084 Novel use application of sugar chain-recognizing receptor |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177056 Non-cytotoxic fusion proteins comprising egf muteins |
| 07/21/2011 | US20110177053 Non-cytotoxic protein conjugates |
| 07/21/2011 | US20110177049 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177034 Probiotic bifidobacterium longum |
| 07/21/2011 | US20110177031 Eicosapentaenoic Acid-Producing Microorganisms, Fatty Acid Compositions, and Methods of Making and Uses Thereof |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177011 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton's tyrosine kinase by such compounds |
| 07/21/2011 | US20110176998 Imaging and therapy of virus-associated tumors |
| 07/21/2011 | DE102009025119B4 Antitumorale, antibiotische und insektizide Cyclodepsipeptide, deren Herstellung und Verwendungen Antitumoral, antibiotic and insecticidal cyclodepsipeptides, their preparation and uses |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2785499A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 07/20/2011 | EP2345637A2 3, 10, and 12a substituted tetracycline compounds |
| 07/20/2011 | EP2345635A1 Amino acid derivative |
| 07/20/2011 | EP2344502A2 Pyrimidinyl pyridone inhibitors of jnk |
| 07/20/2011 | EP2344494A1 Aminotriazolopyridines and their use as kinase inhibitors |
| 07/20/2011 | EP2344493A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344492A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344486A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 07/20/2011 | EP2344484A1 S1p receptors modulators and their use thereof |
| 07/20/2011 | EP2344465A1 Crystalline forms of (r) -5- [3-chloro-4-( 2, 3-dihydroxy-propoxy)-benz [z]ylidene]-2- [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
| 07/20/2011 | EP2344463A2 1,2 -thiazol yl derivatives as cannabinoid receptor ligands |
| 07/20/2011 | EP2344456A1 Novel potassium channel blocker |
| 07/20/2011 | EP2344449A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 07/20/2011 | EP2344441A2 14-hydroxy-docosahexaenoic acid compounds |
| 07/20/2011 | EP2344158A1 Use of isoQC inhibitors |
| 07/20/2011 | EP2344157A1 Novel inhibitors |
| 07/20/2011 | EP2344154A1 Compositions that include anthocyanidins and methods of use |
| 07/20/2011 | EP2247595B1 Pyrrolopyrazine kinase inhibitors |
| 07/20/2011 | EP2125788B9 Heterocyclic compounds, compositions comprising them and methods of their use |
| 07/20/2011 | EP2111228B1 10Fn3 domain for use in treating diseases associated with inappropriate angiogenesis |
| 07/20/2011 | EP1997511B1 Therapeutic agent for rheumatoid arthritis |
| 07/20/2011 | EP1994005B1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 07/20/2011 | EP1496930B1 G-type peptides to ameliorate atherosclerosis |
| 07/20/2011 | EP1324779B1 Pegylated interleukin-10 |
| 07/20/2011 | EP1230237B2 Magnesium omeprazole |
| 07/20/2011 | EP1218007B1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/20/2011 | EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 07/20/2011 | CN1978466B Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 07/20/2011 | CN1977899B Medicine for treating rheumatoid arthritis |
| 07/20/2011 | CN1970032B Chinese medicine containing honeysuckle flower and weeping forsythia for treating cold |
| 07/20/2011 | CN102131806A Triazolopyridine compounds useful as kinase inhibitors |
| 07/20/2011 | CN102131805A Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
| 07/20/2011 | CN102131794A 6-substituted phenoxychroman carboxylic acid derivatives |
| 07/20/2011 | CN102131789A Insceticidal compounds |
| 07/20/2011 | CN102131771A Compositions and methods for preparing and using same |
| 07/20/2011 | CN102131547A Sparc anti-inflammatory activity and uses thereof |
| 07/20/2011 | CN102131504A Combinations comprising bicyclic S1P lyase inhibitors |
| 07/20/2011 | CN102127167A Whole human TNF alpha (tumor necrosis factor alpha) monoclonal antibody and preparation and application thereof |
| 07/20/2011 | CN102127160A Scorpion active polypeptides as well as preparation method and application thereof |
| 07/20/2011 | CN102127141A Esculentoside A, EsA as well as preparation method and application thereof |
| 07/20/2011 | CN102127057A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127056A Tubulin inhibitors |
| 07/20/2011 | CN102127054A 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/20/2011 | CN102127016A Hetisin type diterpenoid alkaloid and preparation method and application thereof |
| 07/20/2011 | CN102126933A Diphenyl propane lignan compound and preparation method thereof |
| 07/20/2011 | CN102125692A Wrapping agent in levo-carnitine wrapping technology and composition of ten series products and preparation method |
| 07/20/2011 | CN102125665A Active plaster for treating blood stasis of human bodies |
| 07/20/2011 | CN102125661A Gastrodia tuber headache tablets and preparation method thereof |
| 07/20/2011 | CN102125643A Traditional Chinese medicinal capsules for treating headache |
| 07/20/2011 | CN102125639A Analgesic |
| 07/20/2011 | CN102125635A Granules for treating common cold |
| 07/20/2011 | CN102125629A Nutrient sea cucumber medicinal liquor |
| 07/20/2011 | CN102125628A Formula of externally applied medicine for quickly expelling wind and clearing away cold and freeing network vessels and removing obstruction in channels |
| 07/20/2011 | CN102125625A Traditional Chinese medicine for treating ankylosing spondylitis |
| 07/20/2011 | CN102125612A Chinese medicinal preparation for treating acute lumbar sprain |
| 07/20/2011 | CN102125610A Xiaojin sustained-release pellets and composition thereof |
| 07/20/2011 | CN102125602A Extract of gentiana macrophylla pall flower and extraction method and application thereof in medicaments |
| 07/20/2011 | CN102125583A Pediatric paracetamol, cow-bezoar and chlorphenamine maleate granules and quality control method thereof |
| 07/20/2011 | CN102125556A Slow release microspheres and injection long-acting preparation of oxycodone or salt of oxycodone |
| 07/20/2011 | CN102125538A Novel nutraceutical compositions and use thereof |
| 07/20/2011 | CN102125529A Slow-release diclofenac potassium tablets |
| 07/20/2011 | CN102125370A Health care wooden drug pillow |